BabelNet

bn:00700306n

Noun Named Entity

No term available

The United States Food and Drug Administration's Investigational New Drug program is the means by which a pharmaceutical company obtains permission to start human clinical trials and to ship an experimental drug across state lines before a marketing application for the drug has been approved. Wikipedia

Relations

Sources

PART OF

investigação clínica

PARTIALLY COINCIDENT WITH

trial master file